• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Dr. Reddy's Laboratories Ltd (RDY)

ADS Common
Sell: $12.06|Buy: $12.41|Change: 0.07 (0.58%)

Open 

$12.13

Previous close 

$12.11

Trade high 

$12.225

Volume 

2,020,637

Year high 

$15.67

Year low 

$11.36

Dividend yield 

0.69%

Market capitalisation 

$10.15 bn

P/E ratio 

29.21

ISIN 

US2561352038

This share can be held in a Dealing accountSIPP

Share price

Dividends

PreviousLatest
Record date10/07/202509/07/2026
Ex-dividend date25/07/202509/07/2026
Payment date06/08/2025Invalid date
Amount$0.09149$0.08336

Performance 21/08/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Dr. Reddy's Laboratories Ltd+ 0.58
More...

Company profile

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%).Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand nameand earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.